Back to HomeKorea StockPremiumAll L&F coverage

L&F (066970.KS) Q1 2026: Revenue Doubles, Operating Swing Driven by ₩136.2B Inventory Reversal

Jun 17, 2026

L&F's first operating profit in six quarters is real in magnitude but fragile in origin — rising lithium prices unwound a cumulative inventory write-down rather than reflecting a structural improvement in cathode margins, while a ₩161.5 billion surge in financial costs pushed the bottom line to a net loss of ₩65.3 billion.

Source: 27th Fiscal Year Q1 Business Report — Filed May 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions

Unlimited U.S.-market analysis, $9.99/month

“L&F (066970.KS) Q1 2026: Revenue Doubles, Operating Swing Driven by ₩136.2B Inventory Reversal”

This article became available on June 17, 2026. Subscribe to read in full, or wait until September 15, 2026 when it becomes free.

Subscribe — $9.99/month

Cancel anytime. Full refund within 7 days.

Access is tied to your account. Subscribe with the same email you sign up with — if you already paid, sign up with that email and it unlocks automatically.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →

This company

Full report on L&F

We read L&F's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the L&F report

Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.

L&F (066970.KS) Q1 2026: Revenue Doubles, Operating Swing Driven by ₩136.2B Inventory Reversal

Unlimited U.S.-market analysis, $9.99/month

Go deeper than the headline

The U.S. market, every morning — free

Full report on L&F

Follow the whole market

Related Stories

How to Read Korean DART Filings in English: A Guide for Foreign Investors

Samsung Electronics Q2 2026: Record KRW 89.5T Profit as MX Posts First Smartphone Loss Since 2011

Celltrion Amends Q2 2026 Earnings Filing, Confirms Record ₩430B Operating Profit

ABL Bio (298380.KQ) Q1 2026: Loss Narrows 48%, ₩186.7B in Cash

EO Technics (039030.KQ) Q1 2026: Operating Profit Doubles as HBM Laser Demand Surges

Samchundang Pharmaceutical (000250.KS) FY2025: Ailia Biosimilar Debut Drives 220% Operating Profit Surge, Swings to Net Profit

OCI Holdings (010060.KS) Q2 2026: Texas Solar Drives 58% Revenue Jump and Third Straight Quarterly Profit

Kolon TissueGene (950160.KQ) Q1 2026: ₩99.9B Net Loss Is 95% Non-Cash Derivatives as TG-C Phase 3 Misses Primary Endpoints

Jusung Engineering (036930.KQ) Q1 2026: Revenue Halves to ₩54.9B as R&D at 46% of Sales Drives ₩7B Operating Loss

Rainbow Robotics (277810.KQ) Q1 2026: Revenue Surges 116.6% as Samsung Subsidy Lifts Scale, But R&D Intensity Widens Operating Loss

Alteogen (196170.KQ) Q1 2026: 120% SG&A Surge Erodes Operating Profit 36% Despite ₩867.5B Biogen Deal

EcoPro (086520.KQ) Q1 2026: ₩247.3B Swing, Gross Margin Doubles